Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Twin-exenatide Study: Switching from twice-daily to once-weekly exenatide in Japanese adults with type 2 diabetes mellitus
jRCTs031180320Completed
- Sponsor
- Hokkaido Health-Science Institute
- Start
- Mar 2015
- Modality
- Peptides
- Countries
- 1
01
Overview
Open-label, single-arm trial of exenatide in type 2 diabetes mellitus (T2DM), sponsored by Hokkaido Health-Science Institute. Primary endpoint: Change in HbA1c at week 24. Started Mar 2015; status: completed.
02
Drugs
exenatide
03
Conditions
type 2 diabetes mellitus (T2DM)
Beyond the preview
Go deeper on jRCTs031180320.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on jRCTs031180320.